Business ❯ Pharmaceuticals

Investment

Manufacturing Research and Development Corporate Strategy Job Creation AstraZeneca Market Expansion International Business Corporate Decisions Economic Impact Production Facilities Private Equity Public Investment Government Funding Dublin Development Clinical Trials U.S. Operations Healthcare Industry Life Sciences Economic Development Trade Healthcare Sector Multinational Companies Supply Chain International Competitiveness Expansion Plans Foreign Direct Investment Contract Manufacturing International Relations Biotechnology US Market Capacity Expansion Mergers and Acquisitions International Expansion Weight Loss Medications Global Markets International Investment International Operations Artificial Intelligence Drug Development Astrazeneca Research Funding Corporate Development Joint Ventures

AstraZeneca Buys Stake in Summit to Pursue Cancer Drug Combinations

The equity purchase funds a research pact to test ivonescimab with AstraZeneca’s cancer medicines to speed combination trials.

Eli Lilly to Invest $3 Billion in China to Build Orforglipron Manufacturing

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

AstraZeneca Pledges $15 Billion China Expansion Through 2030

GSK Pledges $30 Billion U.S. Investment as UK Drug-Pricing Standoff Drives Pullbacks

AstraZeneca Pauses £200m Cambridge Plan as Merck Axes £1bn London Hub

AstraZeneca Commits $50 Billion to U.S. Manufacturing and Research by 2030